IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Baker Bros. Advisors LP

Q2 2025 Holdings

Filed 2025-08-14 | 89 holdings | $10.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Opthea LimitedSPONSORED ADS68386J208$02,087,3200.0%
Surrozen, Inc.(SRZNW)W EXP 8/11/202686889P117$15.1K833,3330.0%
Acrivon Therapeutics, Inc.(ACRV)COMMON STOCK004890109$27.1K22,8090.0%
Tyra Biosciences, Inc.(TYRA)COM90240B106$101.5K10,6070.0%
Aligos Therapeutics, Inc.(ALGS)COM01626L204$598.8K83,0550.0%
Generation Bio Co.(GBIOGBX)COM37148K100$622.6K1,944,9450.0%
Neumora Therapeutics, Inc.(NMRA)COM640979100$758.7K1,034,6000.0%
Hookipa Pharma Inc.(HOOK)COM43906K209$1.0M812,8140.0%
Contineum Therapeutics, Inc.(CTNM)CL A21217B100$1.2M312,5000.0%
Rocket Pharmaceuticals, Inc.(RCKT)COM77313F106$1.4M552,0790.0%
vTv Therapeutics, Inc.(VTVT)CL A918385204$1.5M97,3140.0%
Protara Therapeutics, Inc.(TARA)COM STK74365U107$1.6M536,8320.0%
Candel Therapeutics, Inc.(CADL)COM137404109$1.8M355,1120.0%
Tectonic Therapeutic, Inc.(TECX)COM878972108$2.0M100,0000.0%
Wave Life Sciences Ltd.(WVE)SHSY95308105$2.2M344,0630.0%
Enliven Therapeutics, Inc.(ELVN)COM29337E102$2.3M114,8330.0%
Vir Biotechnology, Inc.(VIR)COM92764N102$2.7M542,5390.0%
Fate Therapeutics, Inc.(FATE)COM31189P102$2.8M2,485,0180.0%
Relay Therapeutics, Inc.(RLAY)COM75943R102$4.0M1,160,1170.0%
TScan Therapeutics, Inc.(TCRX)COM89854M101$4.0M2,784,7920.0%
IGM Biosciences, Inc.(1K0)COM449585108$4.6M4,096,2100.0%
Alumis Inc.(ALMS)COM022307102$4.7M1,562,5000.0%
Xencor, Inc.(XNCR)COM98401F105$5.3M670,4310.1%
Sana Biotechnology, Inc.(SANA)COM799566104$5.5M2,030,9490.1%
Kala BIO, Inc.(KALA)COM483119202$5.7M1,201,8940.1%
Design Therapeutics, Inc.(DSGN)COM25056L103$5.8M1,712,8820.1%
Skye Bioscience, Inc.(SKYE)COM83086J200$6.1M1,450,6380.1%
Rapport Therapeutics, Inc.(RAPP)COM75383L102$6.3M550,0900.1%
Agios Pharmaceuticals, Inc.(AGIO)COM00847X104$6.3M189,8660.1%
Sionna Therapeutics, Inc.(SION)COM829401108$6.9M400,0000.1%
Sagimet Biosciences Inc.(SGMT)COM SER A786700104$7.3M952,9960.1%
CytomX Therapeutics, Inc.(CTMX)COM23284F105$7.9M3,484,2260.1%
Crinetics Pharmaceuticals, Inc.(CRNX)COM22663K107$8.1M280,0000.1%
Prelude Therapeutics Inc.(PRLD)COM74065P101$8.2M10,123,8240.1%
Taysha Gene Therapies, Inc.(TSHA)COM SHS877619106$9.3M4,004,7560.1%
Spyre Therapeutics, Inc.(SYRE)COM00773J202$9.4M626,7030.1%
Nuvalent, Inc.(NUVL)COM670703107$11.0M143,9370.1%
Arcellx, Inc.(ACLX)COMMON STOCK03940C100$11.0M166,8250.1%
Cidara Therapeutics, Inc.(CDTX)COM171757206$11.1M227,2720.1%
Xenon Pharmaceuticals Inc.(XENE)COM98420N105$11.6M370,2080.1%
DBV Technologies S.A.(DBVT)SPONSORED ADS23306J309$13.4M1,461,4250.1%
Celldex Therapeutics, Inc.(CLDX)COM15117B202$13.5M665,3700.1%
Dianthus Therapeutics, Inc.(DNTH)COM252828108$14.7M789,7590.1%
Neurogene Inc.(NGNE)COM64135M105$14.8M991,6910.1%
Arrowhead Pharmaceuticals, Inc.(ARWR)COM04280A100$14.8M939,1740.1%
Sera Prognostics, Inc.(SERA)CLASS A COM81749D107$15.2M5,498,1700.1%
Blueprint Medicines Corporation(2L9)COM09627Y109$16.1M125,5380.2%
Akero Therapeutics, Inc.(AKRO)COM00973Y108$17.3M324,6300.2%
Disc Medicine, Inc.(IRON)COM254604101$17.9M337,0500.2%
Cerus Corporation(CERS)COM157085101$18.2M12,883,8440.2%
Page 1 of 2Next